Latest blood clots Stories
As Testosterone Complaints Continue to Increase, the FDA Furthers Its Investigation into Testosterone Use by Holding a Meeting of Its Advisory Panels to Explore the Safety and Effectiveness of
Testosterone Lawsuit Complaints Alleging AndroGel and Other Prescription Testosterone Treatment Drugs Cause Heart Attacks and Strokes Continue To Climb For Second Straight Month Columbus,
X-VeRT Study Results Presented as a Hot Line Session at the ESC Congress 2014 and Published in European Heart Journal BARCELONA, Spain, Sept.
Randy Fenninger to Lead Organization With Strategic Focus Aimed at Increasing Recognition of Life-Threatening Blood Clots and Their Impact on Public Health Rockville,
With Over 150 AndroGel Lawsuits Pending In The U.S., A Class Action Testosterone Therapy Lawsuit Has Been Filed In Canada Contending AbbVie Failed To Disclose The Health Risks Associated With
The FDA Is Seeking Input From Its Advisory Panels As Testosterone Lawsuits Mount And Reports That Low Testosterone Medication Purportedly Cause Heart Attacks And Strokes Reports Wright & Schulte
Attorney Ronald E. Johnson, Jr. has been appointed co-lead counsel in nationwide lawsuits for men injured by testosterone medications, like AndroGel.
The FDA Has Changed the Medication Guide for the Testosterone Therapy Drug AndroGel to Include The Risks of Blood Clots in the Legs and Lungs as Testosterone Treatment Lawsuits Rise to 156 Filings
With Over 100 Testosterone Lawsuits Awaiting Litigation in the U.S., Health Canada Has Issued A Safety Review Warning of Possible Cardiac Risks Associated With Testosterone Treatment Drugs
Required Change Reflects Reports of Additional Clotting Not Related to Condition Covered by Current Warnings DALLAS (PRWEB) July 17, 2014 The U.S.
- Withering but not falling off, as a blossom that persists on a twig after flowering.